Unknown

Dataset Information

0

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment.

ABSTRACT:

SUBMITTER: Kimura H 

PROVIDER: S-EPMC6823937 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma.
| S-EPMC5354886 | biostudies-literature
Unknown The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M.
| S-EPMC5217000 | biostudies-literature
Unknown Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR-TKI drug resistance.
| S-EPMC5668506 | biostudies-literature
Unknown The Presence of EGFR T790M in TKI-Naive Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is Rare.
| S-EPMC9320221 | biostudies-literature
Unknown An Observational Study of Acquired <i>EGFR</i> T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan.
| S-EPMC7498675 | biostudies-literature
Unknown Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients.
| S-EPMC5095551 | biostudies-literature
Unknown Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
| S-EPMC6614728 | biostudies-literature
Unknown The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma.
| S-EPMC4644829 | biostudies-literature
Unknown AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.
| S-EPMC4315625 | biostudies-literature
Unknown Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation.
| S-EPMC6775702 | biostudies-literature